{"Symbol": "BSTC", "AssetType": "Common Stock", "Name": "BioSpecifics Technologies Corp", "Description": "BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "Delaware Corporate Center II, Wilmington, DE, United States, 19803", "FullTimeEmployees": "7", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "472134016", "EBITDA": "23135740", "PERatio": "25.5202", "PEGRatio": "1.36", "BookValue": "17.62", "DividendPerShare": "None", "DividendYield": "0", "EPS": "2.479", "RevenuePerShareTTM": "4.74", "ProfitMargin": "0.5245", "OperatingMarginTTM": "0.6614", "ReturnOnAssetsTTM": "0.117", "ReturnOnEquityTTM": "0.1522", "RevenueTTM": "34777696", "GrossProfitTTM": "38187755", "DilutedEPSTTM": "2.479", "QuarterlyEarningsGrowthYOY": "-0.982", "QuarterlyRevenueGrowthYOY": "-0.559", "AnalystTargetPrice": "100", "TrailingPE": "25.5202", "ForwardPE": "44.2478", "PriceToSalesRatioTTM": "13.3941", "PriceToBookRatio": "3.592", "EVToRevenue": "10.5244", "EVToEBITDA": "16.2415", "Beta": "0.8527", "52WeekHigh": "69.73", "52WeekLow": "42", "50DayMovingAverage": "64.8353", "200DayMovingAverage": "59.5091", "SharesOutstanding": "7344960", "SharesFloat": "4309285", "SharesShort": "298977", "SharesShortPriorMonth": "277566", "ShortRatio": "8.9", "ShortPercentOutstanding": "0.04", "ShortPercentFloat": "0.042", "PercentInsiders": "26.15", "PercentInstitutions": "66.743", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "2:1", "LastSplitDate": "1992-04-21"}